Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Prepaid Assets (2022 - 2025)

Historic Prepaid Assets for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • Corvus Pharmaceuticals' Prepaid Assets rose 191.67% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 191.67%. This contributed to the annual value of $2.4 million for FY2024, which is 20320.1% up from last year.
  • According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Prepaid Assets is $1.2 million, which was up 191.67% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Corvus Pharmaceuticals' Prepaid Assets peaked at $2.4 million during Q4 2024, and registered a low of $655000.0 during Q1 2023.
  • In the last 4 years, Corvus Pharmaceuticals' Prepaid Assets had a median value of $1.0 million in 2022 and averaged $1.1 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 5008.38% in 2023, then skyrocketed by 20320.1% in 2024.
  • Over the past 4 years, Corvus Pharmaceuticals' Prepaid Assets (Quarter) stood at $773000.0 in 2022, then rose by 1.03% to $781000.0 in 2023, then soared by 203.2% to $2.4 million in 2024, then tumbled by 48.35% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.3 million for Q2 2025, and $1.2 million during Q1 2025.